SABBY MANAGEMENT, LLC
13F Reported Value
ⓘ$45.1M
incl. option notional
Equity Holdings
ⓘ$5.7M
Option Notional
ⓘ$39.4M
$38.5M puts / $857,395 calls
Holdings
28
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
SABBY MANAGEMENT, LLC disclosed 28 positions worth $45.1M in its Form 13F-HR for Q1 2026 — $5.7M in common stock plus $39.4M of put/call option positions (reported at underlying notional value, not premium at risk), led by $SPY (SPDR S&P 500 ETF TRUST) puts. During the quarter the fund opened 10 new positions and exited 17 — including a new stake in $ALP. The portfolio is most concentrated in Other (46.2% of disclosed assets). All figures are sourced directly from SABBY MANAGEMENT, LLC’s Form 13F-HR filing with the SEC under CIK 1535610.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- —
Quality
$29.1M447 sh ISHARES TR PUT
—Quality
$7.4M300 sh- —
Quality
$1.8M2,734 sh - 35.5
Quality
$1.4M5,252 sh - —
Quality
$857.4K77 sh - —
Quality
$654.8K2,072,103 sh BRIACELL THERAPEUTICS CORP
—Quality
$392.1K380,686 sh- —
Quality
$358.4K218,533 sh BIG TREE CLOUD HLDGS LTD
—Quality
$337.1K137,611 sh- 65.6
Quality
$316.9K340 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 SPDR S&P 500 ETF TRUST$SPYPUT | — | $29.1M | 447 |
| ISHARES TR PUT | — | $7.4M | 300 |
| SPDR S&P 500 ETF TRUST$SPY | — | $1.8M | 2,734 |
 Gevo, Inc.$GEVOPUT | 35.5 | $1.4M | 5,252 |
 Abivax S.A.$ABVXCALL | — | $857.4K | 77 |
 Alpha Compute Corp$ALP | — | $654.8K | 2,072,103 |
| BRIACELL THERAPEUTICS CORP | — | $392.1K | 380,686 |
 SenesTech, Inc.$SNES | — | $358.4K | 218,533 |
| BIG TREE CLOUD HLDGS LTD | — | $337.1K | 137,611 |
 ZEVRA THERAPEUTICS, INC.$ZVRAPUT | 65.6 | $316.9K | 340 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of SABBY MANAGEMENT, LLC's 28 positions.
Showing top 10 of 28 holdings.
Sector Allocation
Other
$2.6M
Healthcare
$1.3M
Financials
$654,785
Materials
$508,394
Industrials
$241,686
Communication Services
$201,129
Energy
$158,085
Technology
$8,666
Full Holdings — SABBY MANAGEMENT, LLC (Q1 2026)
All 28 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $SPYPUT | SPDR S&P 500 ETF TRUST | $29.1M | — | +28% | — |
| 2 | — | ISHARES TR | $7.4M | — | -54% | — |
| 3 | $SPY | SPDR S&P 500 ETF TRUST | $1.8M | 31.1% | +716% | — |
| 4 | $GEVOPUT | Gevo, Inc. | $1.4M | — | -16% | 35.5 |
| 5 | $ABVXCALL | Abivax S.A. | $857,395 | — | -52% | — |
| 6 | $ALP | Alpha Compute Corp | $654,785 | 11.5% | NEW | — |
| 7 | — | BRIACELL THERAPEUTICS CORP | $392,145 | 6.9% | +43% | — |
| 8 | $SNES | SenesTech, Inc. | $358,394 | 6.3% | +4% | — |
| 9 | — | BIG TREE CLOUD HLDGS LTD | $337,147 | 5.9% | -98% | — |
| 10 | $ZVRAPUT | ZEVRA THERAPEUTICS, INC. | $316,880 | — | +4% | 65.6 |
| 11 |  $BCTX | BriaCell Therapeutics Corp. | $309,704 | 5.4% | NEW | — |
| 12 | — | SIDUS SPACE INC | $243,368 | — | NEW | — |
| 13 |  $TC | Token Cat Ltd | $241,686 | 4.2% | NEW | — |
| 14 |  $CPOP | Pop Culture Group Co., Ltd | $201,129 | 3.5% | -31% | — |
| 15 |  $MBRX | Moleculin Biotech, Inc. | $171,798 | 3.0% | NEW | — |
| 16 |  $BDRX | Biodexa Pharmaceuticals Plc | $159,092 | 2.8% | +35% | — |
| 17 |  $RKDA | Arcadia Biosciences, Inc. | $158,085 | 2.8% | NEW | — |
| 18 |  $TRX | TRX GOLD Corp | $150,000 | 2.6% | NEW | 50.2 |
| 19 |  $INM | InMed Pharmaceuticals Inc. | $142,046 | 2.5% | +9% | — |
| 20 |  $CANF | Can-Fite BioPharma Ltd. | $131,933 | 2.3% | NEW | — |
| 21 | — | CHINA SXT PHARMACEUTICALS INC | $131,326 | 2.3% | NEW | — |
| 22 |  $REVB | REVELATION BIOSCIENCES, INC. | $119,318 | 2.1% | -84% | — |
| 23 |  $CLDI | Calidi Biotherapeutics, Inc. | $103,855 | 1.8% | NEW | — |
| 24 |  $BJDX | Bluejay Diagnostics, Inc. | $52,856 | 0.9% | NEW | — |
| 25 |  $LYRA | Lyra Therapeutics, Inc. | $51,103 | 0.9% | -41% | — |
| 26 |  $TPST | Tempest Therapeutics, Inc. | $29,284 | 0.5% | -90% | — |
| 27 | $BCTX | BriaCell Therapeutics Corp. | $28,945 | 0.5% | -22% | — |
| 28 |  $BNBX | BNB PLUS CORP. | $8,666 | 0.1% | -75% | — |
New Positions (10)
$ALP Alpha Compute Corp$654,785$TC Token Cat Ltd$241,686$MBRX Moleculin Biotech, Inc.$171,798$RKDA Arcadia Biosciences, Inc.$158,085$TRX TRX GOLD Corp$150,000$CANF Can-Fite BioPharma Ltd.$131,933$CLDI Calidi Biotherapeutics, Inc.$103,855$BJDX Bluejay Diagnostics, Inc.$52,856Exited Positions (17)
$EMPD Empery Digital Inc.
$BLNK Blink Charging Co.
$BTM Bitcoin Depot Inc.$ABVX Abivax S.A.
$ZONE CleanCore Solutions, Inc.
$JZXN Jiuzi Holdings, Inc.
$GVH Globavend Holdings Ltd
$TIRX TIAN RUIXIANG HOLDINGS LTD
$NVA Nova Minerals Corp
$NUWE Nuwellis, Inc.
$EEIQ EpicQuest Education Group International Ltd
$PMCB PharmaCyte Biotech, Inc.
$OGEN ORAGENICS INCBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for SABBY MANAGEMENT, LLC including:
Track SABBY MANAGEMENT, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for SABBY MANAGEMENT, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: SABBY MANAGEMENT, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For SABBY MANAGEMENT, LLC (SEC CIK: 1535610), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in SABBY MANAGEMENT, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.